Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Robarts Research Institute, |
RCV000408831 | SCV000484836 | uncertain significance | Hypercholesterolemia, familial, 1 | criteria provided, single submitter | clinical testing | ||
Phosphorus, |
RCV001823727 | SCV002073409 | uncertain significance | not specified | 2022-01-18 | criteria provided, single submitter | clinical testing | This missense variant results in an amino acid substitution of Arginine with Cysteine at codon 2444 of the APOB gene (transcript: NM_000384.2). This variant has an entry in ClinVar (369884) NM_000384.3(APOB):c.7330C>T (p.Arg2444Cys). This variant occurred in gnomAD with a total MAF of 0 0.0086%and with the highest MAF of 0.0149% in the Latin American population. This position is not conserved. In silico functional algorithms predict this variant to be benign (PolyPhen) and damaging (SIFT). However, no functional studies were performed to confirm either of those predictions. The variant has not occurred in the literature in association with the disease. Considering that this is a rare variant and the available evidence is not enough to ascertain its role in disease, it has been classified as Variant of Uncertain Significance. |
Labcorp Genetics |
RCV002524613 | SCV003350499 | likely benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2024-01-31 | criteria provided, single submitter | clinical testing |